AMIODARONE HYDROCHLORIDE

1. PURPOSE

To authorize CCP’s to initiate or monitor existing intravenous Amiodarone Hydrocholoride infusions

2. POLICY

2.1. CCP’s are permitted to initiate or monitor Amiodarone Hydrochloride infusions

3. PRECAUTIONS

3.1. Y injection incompatibility with the following will precipitate with Amiodarone Hydrochloride:

3.1.1. Heparin Sodium
3.1.2. Sodium Bicarbonate

3.2. Amiodarone should not be given in the presence of ventricular escape rhythm or other

bradycardias.

3.3. Amiodarone concentrations should not exceed 2 mg/ml unless a preexisting central venous

catheter is used in infusions being administered greater than 1 hour in duration.

4. PROCEDURE

4.1. The following parameters shall apply to all patients with Amiodarone infusions:

4.1.1. Due to initial bolus given over time an IV infusion pump must be used
4.1.2. Vital signs must be monitored more frequently than every 15 minutes

5. ADMINISTRATION

5.1. Pulsing monomorphic V-Tach:

5.1.1. Adults – 150 mg mixed in 100 ml NS over 10 minutes and may repeat q 10 minutes prn.
5.1.2. Peds – 5 mg/kg (max 300 mg) mixed in 100 ml NS over 20 mins. Pediatric patients with a
pulse, bolus and/or continuous infusion, requires a physician consult to obtain direction and
dosing.

5.2. For patients who have received bolus doses of Amiodarone, it may be appropriate to establish an

infusion by mixing 450 mg in 250 ml D5W (not NS) and initiate at 1 mg/min to a maximum
cumulative dose of 2.2 grams IV over 24 hours.

10

